Search

Your search keyword '"Scott, David"' showing total 653 results

Search Constraints

Start Over You searched for: Author "Scott, David" Remove constraint Author: "Scott, David" Database ScienceDirect Remove constraint Database: ScienceDirect
653 results on '"Scott, David"'

Search Results

2. Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

4. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)

7. Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma

9. Medical management and surgery versus medical management alone for symptomatic cerebral cavernous malformation (CARE): a feasibility study and randomised, open, pragmatic, pilot phase trial

11. Addressing barriers and identifying facilitators to support informed consent and recruitment in the Cavernous malformations A Randomised Effectiveness (CARE) pilot phase trial: insights from the integrated QuinteT recruitment intervention (QRI)

12. ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis

15. Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

25. Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma

26. Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns

29. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

30. Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population

33. Systematic reviews and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: mortality, morbidity, and organ failure

34. Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type diffuse large B-cell lymphoma

35. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

36. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

38. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

40. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

43. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Catalog

Books, media, physical & digital resources